SAIF, Innovation Works back China healthcare start-up
SAIF Partners and Innovation Works have provided a Series A round of funding for Beijing Dnurse Technology, a Chinese company that develops technology used to track sugar levels in the body.
Financial terms were not disclosed but the investment is said to be worth tens of million in renminbi.
The company produces a smart phone-compatible glucose monitor that transfers data to cloud computing systems. Users put a tiny amount of blood in the monitor and plug it into mobile device's headphone jack to analyze their blood sugar levels. The technology is expected to be of particular use to diabetes sufferers.
With new investment, Dnurse plans to launch new version of its product later this month, according to local media.
More on Greater China
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.